1933 IndustriesTGIFF FCF Margin % is 25.87% as of Jan. 2026. The stock has 2 warning signs investors should review. Among 956 Drug Manufacturers companies, 1933 Industries ranks better than 84.73% on this metric.
The historical rank and industry rank for 1933 Industries's FCF Margin % or its related term are showing as below:
TGIFF'
s FCF Margin % Range Over the Past 10 Years
Min: -222.62 Med: -42.77 Max: 16.98
Current: 16.98
During the past 13 years, the highest FCF Margin % of 1933 Industries was 16.98%. The lowest was -222.62%. And the median was -42.77%.
TGIFF's FCF Margin % is ranked better than 84.73% of 956
companies
in the Drug Manufacturers industry
Industry Median: 2.48
vs TGIFF: 16.98
1933 Industries FCF Margin % Related Terms
1933 Industries FCF Margin % Historical Data
* Premium members only.
The historical data trend for 1933 Industries's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, 1933 Industries's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
1933 Industries FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, 1933 Industries's FCF Margin % distribution charts can be found below:
* The bar in red indicates where 1933 Industries's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
1933 Industries (TGIFF) has a FCF Margin % of 25.87% as of Jan. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 1933 Industries and its competitors. According to the industry distribution chart, 1933 Industries ranks #146 out of 956 companies in the Drug Manufacturers industry, placing it in the top 15.3%.
Is 1933 Industries' FCF Margin % too high?
1933 Industries' current FCF Margin % is 25.87%. The Drug Manufacturers industry median FCF Margin % is 2.48. 1933 Industries' value of 25.87% is 943.1% above this industry median. Based on the distribution chart, 1933 Industries ranks #146 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does 1933 Industries' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, 1933 Industries ranks #146 out of 956 companies for FCF Margin %. This places 1933 Industries in the top 15% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.48. 1933 Industries' value of 25.87% is 943.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 1933 Industries's current FCF Margin % of 25.87% is 943.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 1933 Industries and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1933 Industries's current FCF Margin % is 25.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1933 Industries stock overvalued right now?
Based on GuruFocus' analysis, 1933 Industries (TGIFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 55% below its estimated fair value. The current FCF Margin % is 25.87% and 943.1% above the Drug Manufacturers industry median of 2.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For 1933 Industries (TGIFF), the current FCF Margin % is 25.87% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGIFF has been successfully added to your 